2-(4,5-Dihydrofuran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-cyanophenyl)propanoic acid, 95.0%, 1g

2-[4-(4-fluorophenoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

5-Bromo-3,3-difluoro-2,3-dihydro-1H-indol-2-one, 98%, 250mg

3-(1-Methyl-1h-1,2,4-triazol-5-yl)morpholine, 95%, 250mg

Pentanoic acid methyl-(2-methylamino-ethyl)-amide, 98.0%, 5g

2,3-Dibromobenzo[b]thiophene, 95.0%, 10g

BENZYL 4-(TERT-BUTOXYCARBONYL)BENZYLCARBAMATE, 95.0%, 250mg

2,5-Dichloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

Lucitanib, 98.94%, 25mg

5-(3-Cyanophenyl)isoxazole-3-carboxylic acid, 95.0%, 100mg

4-Fluorostyrene (stabilised with TBC), 95.0%, 10g

2-(Chloromethyl)-5-methoxypyridine hydrochloride, 95.0%, 100mg